DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Dexchlorpheniramine

Dexchlorpheniramine

  • Product Information

    Product Information

  • Report Update 1

    Report Update 1

  • Antihistamine Therapy in Allergic Rhinitis

    Antihistamine Therapy in Allergic Rhinitis

  • Trends in Prescription Medication Use Among Children and Adolescents— United States, 1999-2014

    Trends in Prescription Medication Use Among Children and Adolescents— United States, 1999-2014

  • POLARAMINE® Repetabs (Red and Colour Free), Tablets (Red and Colour Free) and Syrup Dexchlorpheniramine Maleate

    POLARAMINE® Repetabs (Red and Colour Free), Tablets (Red and Colour Free) and Syrup Dexchlorpheniramine Maleate

  • Deleterious Effects of IL-9–Activated Mast Cells and Neuroprotection by Antihistamine Drugs in the Developing Mouse Brain

    Deleterious Effects of IL-9–Activated Mast Cells and Neuroprotection by Antihistamine Drugs in the Developing Mouse Brain

  • HIGH RISK MEDICATIONS As Specified by NCQA’S HEDIS Measure: Use of High Risk Medications in the Elderly

    HIGH RISK MEDICATIONS As Specified by NCQA’S HEDIS Measure: Use of High Risk Medications in the Elderly

  • Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

    Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

  • Technical File Or Summary of the Characteristics of The

    Technical File Or Summary of the Characteristics of The

  • Medicines in Pregnancy

    Medicines in Pregnancy

  • First-Generation Antihistamines (Medications Commonly Used To

    First-Generation Antihistamines (Medications Commonly Used To

  • The Relation Between Antihistamine Medication During Early Pregnancy & Birth Defects

    The Relation Between Antihistamine Medication During Early Pregnancy & Birth Defects

  • High-Risk Medications in the Elderly

    High-Risk Medications in the Elderly

  • ITC Antihistamines-Oral

    ITC Antihistamines-Oral

  • Medication Instructions for Allergy Patients

    Medication Instructions for Allergy Patients

  • These Medications Should Not Be Taken at Least 14 Days Before Skin Testing**

    These Medications Should Not Be Taken at Least 14 Days Before Skin Testing**

  • Perioperative Medication Management - Adult/Pediatric - Inpatient/Ambulatory Clinical Practice Guideline

    Perioperative Medication Management - Adult/Pediatric - Inpatient/Ambulatory Clinical Practice Guideline

  • 2017 Use of High-Risk Medications in the Elderly (HRM) REVISED Based on 2015 AGS Beers Criteria

    2017 Use of High-Risk Medications in the Elderly (HRM) REVISED Based on 2015 AGS Beers Criteria

Top View
  • Ep 2301628 A1
  • Clemastine, the H1 Histamine Receptor Antagonist, Alters the Human Sex and Thyroid Hormonal Profiles
  • Dexchlorpheniramine Maleate Oral Solution, USP Rx Only
  • (12) United States Patent (Lo) Patent No.: US 8,480,637 B2
  • Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
  • Antihistamines and Driving-Related Behavior: a Review of the Evidence for Impairment by First- Versus Second-Generation H1-Antagonists
  • Antihistamines
  • Mebhydrolin Napadisylate
  • Use of Combinations Comprising a Corticosteroid and a Pyrimidopyrimidine in the Treatment of Inflammatory Diseases
  • Potentially Harmful Drugs in the Elderly: Beers List and More
  • Prescribing Focus
  • Medications to Avoid in the Elderly Adapted from NCQA’S HEDIS® Measure, Use of High-Risk Medications in the Elderly
  • Photosensitizing Drugs
  • Our Parents, Ourselves: Health Care for an Aging Population
  • Patient Information Leaflet
  • Management of Drug Overdose and Poisoning
  • CMS: High-Risk Medications (Relevant for Older People Defined As Greater Than 65 Years of Age)
  • Medications That Interfere with Skin Testing If Possible, STOP the Following Medications for ONE WEEK Prior to Your Appointment If Skin Testing Needs to Be Performed


© 2024 Docslib.org    Feedback